Towards Healthcare
Cellular Health Screening Market Hits USD 3.68 Billion in 2025 with 9.24% CAGR

Cellular Health Screening Market Expands in 2025 with Telomere and Blood Testing Leading the Way

Market insights predict the global cellular health screening industry will increase from USD 3.37 billion in 2024 to USD 8.14 billion by 2034, achieving a CAGR of 9.24%. The rising prevalence of chronic disorders and technological advancements drive the global market. Whereas, the presence of a robust healthcare infrastructure and increasing investments contribute to North America’s dominance. 

  • Insight Code: 5846
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The cellular health screening market is projected to reach USD 3.37 billion by 2034, growing at a CAGR of 9.24% from 2025 to 2034.

North America is leading the cellular health screening market due to the presence of a robust healthcare infrastructure, increasing investments, and rising awareness of early disease diagnosis.

The cellular health screening market comprises six segments by test type, by sample type, by collection site, by application, by end-use, and by region.

Some key players include SpectraCell Diagnostics, Quest Diagnostics, and Guardant Health.

Key trends include the rising prevalence of chronic disorders, technological advancements, and growing demand for personalized medicines.

Cellular health determines how overall health relies on the body cells and their functioning. It can be maintained by eating nutritious foods, exercising regularly, and reducing stress levels.

Vitamin B complex, curcumin, milk thistle, magnesium, glutathione, and probiotics are some of the common supplements for cellular health.

World Health Organization, Centers for Disease Control and Prevention, Canadian Medical Association, GOV.UK